Browsing Tag
Gorlin syndrome
3 posts
SkinJect trial clearance gives Medicus Pharma a regulatory win as Nasdaq pressure builds
Medicus Pharma gains FDA clearance for its SkinJect Gorlin syndrome trial as stricter endpoints, secured debt and Nasdaq risks shape the outlook.
Why clinicians are watching SkinJect as a potential alternative to repeated Mohs surgery
Find out how SkinJect could challenge repeated Mohs surgery and reshape basal cell carcinoma care. Read the full analysis now.
Sol-Gel acquires Gorlin syndrome drug candidate Patidegib from PellePharm
Sol-Gel Technologies, an Israel-based dermatology company, has acquired patidegib, a Gorlin syndrome drug candidate in phase 3 development,…